Revenue Breakdown
Composition ()
No data
Revenue Streams
Elanco Animal Health Inc (ELAN) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Farm Animal, accounting for 52.2% of total sales, equivalent to $593.00M. Other significant revenue streams include Pet Health and Contract Manufacturing. Understanding this composition is critical for investors evaluating how ELAN navigates market cycles within the Pharmaceuticals industry.
Profitability & Margins
Evaluating the bottom line, Elanco Animal Health Inc maintains a gross margin of 41.07%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 2.37%, while the net margin is -2.99%. These profitability ratios, combined with a Return on Equity (ROE) of 0.54%, provide a clear picture of how effectively ELAN converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, ELAN competes directly with industry leaders such as SMMT and RNA. With a market capitalization of $12.09B, it holds a leading position in the sector. When comparing efficiency, ELAN's gross margin of 41.07% stands against SMMT's N/A and RNA's 100.00%. Such benchmarking helps identify whether Elanco Animal Health Inc is trading at a premium or discount relative to its financial performance.
